Retour
15
Fourchette du Jour
11,83 €
12,21 €
Fourchette 52 Semaines
11,11 €
27,63 €
Volume
977 668
Moyenne 50J / 200J
13,78 €
/
18,32 €
Clôture Précédente
12,02 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -8,5 | 0,4 |
| P/B | 2,4 | 2,9 |
| ROE % | -26,3 | 3,8 |
| Net Margin % | -40,4 | 3,9 |
| Rev Growth 5Y % | 16,7 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Hold
18,50 €
+55.9%
Low: 18,00 €
High: 19,00 €
BPA Prévisionnel
-2,12 €
CA Est.
250 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,58 €
0,50 € – 0,72 €
|
430 M | 1 |
| FY2029 |
0,13 €
0,11 € – 0,16 €
|
390 M | 1 |
| FY2028 |
-0,39 €
-1,66 € – 1,02 €
|
330 M | 3 |
Points Clés
Revenue grew 16,70% annually over 5 years — strong growth
Debt/Equity of 0,30 — conservative balance sheet
Generating 12,46M in free cash flow
PEG of 0,28 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6,59%
Capital efficient — spends only 0,56% of revenue on capex
Croissance
Revenue Growth (5Y)
16,70%
Revenue (1Y)23,29%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-26,29%
ROIC-26,45%
Net Margin-40,36%
Op. Margin-65,23%
Sécurité
Debt / Equity
0,30
Current Ratio2,75
Interest Coverage0,00
Valorisation
P/E Ratio
-8,49
P/B Ratio2,41
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23,29% | Revenue Growth (3Y) | 8,67% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 16,70% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 255,87M | Net Income (TTM) | -103,27M |
| ROE | -26,29% | ROA | -14,22% |
| Gross Margin | 55,74% | Operating Margin | -65,23% |
| Net Margin | -40,36% | Free Cash Flow (TTM) | 12,46M |
| ROIC | -26,45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,30 | Current Ratio | 2,75 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -8,49 | P/B Ratio | 2,41 |
| P/S Ratio | 3,42 | PEG Ratio | 0,28 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 876,30M | Enterprise Value | 755,02M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 255,87M | 207,54M | 216,67M | 180,96M | 137,93M |
| Net Income | -103,27M | -187,12M | 40,72M | -149,19M | -100,39M |
| EPS (Diluted) | -1,41 | -2,57 | 0,54 | -2,10 | -1,43 |
| Gross Profit | 142,61M | 132,08M | 140,69M | 101,02M | 65,62M |
| Operating Income | -166,90M | -209,30M | -177,45M | -146,82M | -111,44M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 726,16M | 823,23M | 802,96M | 688,59M | 756,49M |
| Total Liabilities | 362,11M | 401,78M | 254,40M | 240,68M | 199,40M |
| Shareholders' Equity | 364,05M | 421,45M | 548,56M | 447,89M | 557,07M |
| Total Debt | 109,23M | 117,83M | 127,88M | 116,49M | 79,87M |
| Cash & Equivalents | 230,52M | 147,33M | 155,32M | 90,47M | 120,27M |
| Current Assets | 519,27M | 634,99M | 567,80M | 533,99M | 625,06M |
| Current Liabilities | 189,14M | 191,75M | 133,67M | 108,80M | 91,21M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#137 of 146
Activité Récente
Entré
Full Throttle
Mar 24, 2026